| FDA Considers Action Against J&J The FDA is considering "additional enforcement actions" that might include criminal penalties against the Johnson & Johnson unit that makes Tylenol. online.wsj.com |
Thermo Fisher Scientific Q2 2010 Earnings Call Transcript Thermo Fisher Scientific (TMO)Q2 2010 Earnings CallJuly 27, 2010 8:30 am ETComplete Story » seekingalpha.com |
J&J Borrows at Record-Low Rates Johnson & Johnson sold $1.1 billion of bonds at the lowest rates ever for 10-year and 30-year corporate debt securities, illustrating how eager investors are to buy corporate bonds at a time of record-low yields on government debt. online.wsj.com |
Boehringer Halts 'Pink Viagra' Germany's Boehringer Ingelheim said it has stopped developing an oral pill designed to treat low-sex drive in women after failing to convince U.S authorities that the medicine works. online.wsj.com |
Cord Blood America Updates Its Stem Cell Collection Business in China [PR Newswire] - Cord Blood America, Inc. , the umbilical cord blood stem cell preservation company focused on bringing the life saving potential of stem cells to families nationwide and internationally, today announced its Chairman, CEO and co-founder, Matthew Schissler, has updated progress on the Company's stem cell collection business in China in an interview with analyst Francis Gaskins. us.rd.yahoo.com |